Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma.
作者信息
Herraez Elisa, Romero Marta R, Macias Rocio I R, Monte Maria J, Marin Jose J G
机构信息
Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
出版信息
Hepatobiliary Surg Nutr. 2020 Apr;9(2):211-214. doi: 10.21037/hbsn.2019.10.11.
Abstract
摘要
相似文献
1
Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma.肝内胆管癌患者肠道微生物群变化与胆汁酸代谢之间关系的临床相关性
Hepatobiliary Surg Nutr. 2020 Apr;9(2):211-214. doi: 10.21037/hbsn.2019.10.11.
2
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.肝脏良性胆管病变的组织病理学：肝内胆管癌的形态学模仿者还是前驱病变？
Clin Mol Hepatol. 2016 Sep;22(3):400-405. doi: 10.3350/cmh.2016.0105.
3
Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).金属硫蛋白过表达及其在肝内胆管癌和肝外肝门胆管癌（克氏瘤）中的预后相关性。
Hum Pathol. 2009 Dec;40(12):1706-14. doi: 10.1016/j.humpath.2009.01.026. Epub 2009 Aug 14.
4
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
5
Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.肝内胆管结石所致胆管癌的凝集素组织化学研究
J Surg Oncol. 1995 Jun;59(2):131-5. doi: 10.1002/jso.2930590211.
6
Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.水通道蛋白-1在肝内胆管癌中的下调与肿瘤进展及黏蛋白表达有关。
Hum Pathol. 2007 Dec;38(12):1819-25. doi: 10.1016/j.humpath.2007.04.016. Epub 2007 Sep 14.
7
Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.伴有胆管癌成分及显著胆管播散的肝内癌肉瘤
Int J Surg Pathol. 2019 Dec;27(8):900-906. doi: 10.1177/1066896919855766. Epub 2019 Jun 17.
8
Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.肌腱蛋白、IV型胶原和层粘连蛋白在人肝内胆管发育及肝内胆管癌中的表达
Histopathology. 1994 Aug;25(2):143-50. doi: 10.1111/j.1365-2559.1994.tb01570.x.
9
The Role of the Gut Microbiota in Bile Acid Metabolism.肠道微生物群在胆汁酸代谢中的作用。
Ann Hepatol. 2017 Nov;16 Suppl 1:S21-S26. doi: 10.5604/01.3001.0010.5672.
10
DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.DLEC1 甲基化与小胆管型肝内胆管细胞癌患者的更好临床结局相关。
Virchows Arch. 2019 Jul;475(1):49-58. doi: 10.1007/s00428-018-02511-7. Epub 2019 Jan 4.
引用本文的文献
1
The Role of the Gut-Biliary-Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications.肠道-胆管-肝脏轴在原发性肝胆管癌中的作用：从分子洞察到临床应用
J Pers Med. 2025 Mar 24;15(4):124. doi: 10.3390/jpm15040124.
2
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.肠道微生物代谢物在原发性肝癌发病机制中的作用。
Nutrients. 2024 Jul 22;16(14):2372. doi: 10.3390/nu16142372.
3
Causal roles of gut microbiota in cholangiocarcinoma etiology suggested by genetic study.基因研究提示肠道微生物群在胆管癌病因学中的因果作用。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1319-1333. doi: 10.4251/wjgo.v16.i4.1319.
4
Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma.鉴定和验证一个与乳酸代谢相关的六个基因的预后签名，用于肝内胆管癌。
J Cancer Res Clin Oncol. 2024 Apr 16;150(4):199. doi: 10.1007/s00432-024-05723-4.
5
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.肿瘤微生物组的特征及其与肝内胆管癌预后的关系。
J Gastroenterol. 2024 May;59(5):411-423. doi: 10.1007/s00535-024-02090-2. Epub 2024 Mar 10.
6
Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy.人类微生物组与胆管癌之间的相互作用：对发病机制和治疗的影响
Microorganisms. 2023 Oct 20;11(10):2598. doi: 10.3390/microorganisms11102598.
7
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases.从微生物组角度看胆道疾病：微生物如何改变良性和恶性疾病的治疗方法
Microorganisms. 2022 Jan 28;10(2):312. doi: 10.3390/microorganisms10020312.
8
Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment.肝癌中的肠道微生物群与免疫系统：从发生到治疗的潜在治疗意义
World J Gastrointest Oncol. 2021 Nov 15;13(11):1616-1631. doi: 10.4251/wjgo.v13.i11.1616.
9
Application of metabolomics in clinical and laboratory gastrointestinal oncology.代谢组学在临床和实验室胃肠肿瘤学中的应用。
World J Gastrointest Oncol. 2021 Jun 15;13(6):536-549. doi: 10.4251/wjgo.v13.i6.536.
本文引用的文献
1
Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma.肝内胆管癌的肠道微生物群特征、胆汁酸代谢和细胞因子。
Hepatology. 2020 Mar;71(3):893-906. doi: 10.1002/hep.30852. Epub 2019 Aug 19.
2
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma.肠道微生物群在早期肝细胞癌患者中的诊断和治疗潜力
Ther Adv Med Oncol. 2019 May 10;11:1758835919848184. doi: 10.1177/1758835919848184. eCollection 2019.
3
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.血清代谢物作为胆管癌、肝细胞癌和原发性硬化性胆管炎的诊断生物标志物。
Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14.
4
Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.发现甘氨胆酸和牛磺鹅脱氧胆酸作为胆管癌的表型生物标志物。
Sci Rep. 2018 Jul 23;8(1):11088. doi: 10.1038/s41598-018-29445-z.
5
Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.血清胆汁酸组成模式及血清甘氨胆酸水平在胆管癌中的诊断价值
Oncol Lett. 2017 Oct;14(4):4943-4948. doi: 10.3892/ol.2017.6763. Epub 2017 Aug 17.
6
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.胆管癌新型诊断和预后生物标志物的研究。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1468-1477. doi: 10.1016/j.bbadis.2017.08.002. Epub 2017 Aug 4.
7
Chemoresistance and chemosensitization in cholangiocarcinoma.胆管癌的化疗耐药和化疗增敏。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1444-1453. doi: 10.1016/j.bbadis.2017.06.005. Epub 2017 Jul 7.
8
Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.肠肝循环中Fgf15信号的改变及胆汁酸组成的变化取决于小鼠肠道炎症的部位。
Inflamm Bowel Dis. 2016 Oct;22(10):2382-9. doi: 10.1097/MIB.0000000000000879.
9
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.组织微生物组分析确定了华支睾吸虫相关胆管癌中特定肠道细菌的富集。
EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034. Epub 2016 May 6.
10
Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.血清和胆汁中胆管癌潜在的诊断和预后生物标志物。
Biomark Med. 2016 Jun;10(6):613-9. doi: 10.2217/bmm-2015-0062. Epub 2016 May 27.
Zotero 插件